Operating Profit Margin
since 2005
Calculation
Abiomed Inc., operating profit margin, long-term trends, calculation
| Operating profit margin | = | 100 | × | Income (loss) from operations1 | ÷ | Revenue1 | |
|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | 13.64% | = | 100 | × | 140,720) | ÷ | 1,031,753) |
| Mar 31, 2021 | 27.09% | = | 100 | × | 229,557) | ÷ | 847,522) |
| Mar 31, 2020 | 29.64% | = | 100 | × | 249,219) | ÷ | 840,883) |
| Mar 31, 2019 | 29.22% | = | 100 | × | 224,812) | ÷ | 769,432) |
| Mar 31, 2018 | 26.47% | = | 100 | × | 157,137) | ÷ | 593,749) |
| Mar 31, 2017 | 20.24% | = | 100 | × | 90,138) | ÷ | 445,304) |
| Mar 31, 2016 | 19.76% | = | 100 | × | 65,104) | ÷ | 329,543) |
| Mar 31, 2015 | 12.45% | = | 100 | × | 28,666) | ÷ | 230,311) |
| Mar 31, 2014 | 4.55% | = | 100 | × | 8,363) | ÷ | 183,643) |
| Mar 31, 2013 | 10.46% | = | 100 | × | 16,543) | ÷ | 158,124) |
| Mar 31, 2012 | 1.20% | = | 100 | × | 1,520) | ÷ | 126,375) |
| Mar 31, 2011 | -11.06% | = | 100 | × | (11,185) | ÷ | 101,151) |
| Mar 31, 2010 | -29.26% | = | 100 | × | (25,076) | ÷ | 85,713) |
| Mar 31, 2009 | -40.32% | = | 100 | × | (29,518) | ÷ | 73,210) |
| Mar 31, 2008 | -61.90% | = | 100 | × | (36,487) | ÷ | 58,941) |
| Mar 31, 2007 | -56.29% | = | 100 | × | (28,511) | ÷ | 50,649) |
| Mar 31, 2006 | -69.36% | = | 100 | × | (30,291) | ÷ | 43,670) |
| Mar 31, 2005 | -8.51% | = | 100 | × | (3,253) | ÷ | 38,216) |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1 US$ in thousands
The operational performance from 2005 to 2022 is characterized by a transition from significant early-stage losses to a period of high profitability, followed by a recent contraction in operational efficiency.
- Phase of Operational Deficits (2005–2011)
- The company experienced consistent operating losses during this period. A sharp decline in the operating profit margin occurred between 2005 and 2006, dropping from -8.51% to a low of -69.36%. Following this trough, a steady recovery trend is observed, with margins improving to -11.06% by 2011. This recovery occurred despite operating losses remaining in the millions, indicating that revenue growth began to outpace the growth of operating expenses.
- Transition to Profitability and Expansion (2012–2015)
- The fiscal year ending March 31, 2012, marked a pivotal turnaround with the achievement of a positive operating profit margin of 1.20%. This was followed by a general upward trajectory in profitability. Although a temporary dip to 4.55% occurred in 2014, the margin rebounded strongly to 12.45% in 2015, establishing a foundation for sustained operational profitability.
- Peak Operational Efficiency (2016–2020)
- A period of significant margin expansion is evident from 2016 to 2020. The operating profit margin climbed steadily from 19.76% in 2016 to a peak of 29.64% in 2020. This growth was supported by a substantial increase in revenue, which rose from $329.54 million in 2015 to $840.88 million in 2020, demonstrating strong economies of scale and effective cost management during this window.
- Recent Margin Contraction (2021–2022)
- A reversal in the profitability trend is observed after 2020. While revenue continued to grow, reaching $1.03 billion by March 31, 2022, the operating profit margin declined to 27.09% in 2021 and fell sharply to 13.64% in 2022. This suggests that operating expenses increased at a rate significantly higher than revenue growth during the final two years of the analyzed period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Comparison to Competitors
Abiomed Inc., operating profit margin, long-term trends, comparison to competitors
| Abiomed Inc. | Abbott Laboratories | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|
| Mar 31, 2022 | 13.64% | 19.16% | 25.35% | 18.15% | 8.83% |
| Mar 31, 2021 | 27.09% | 19.56% | 31.89% | 14.89% | 8.40% |
| Mar 31, 2020 | 29.64% | 15.48% | 24.09% | 16.57% | 8.76% |
| Mar 31, 2019 | 29.22% | 14.21% | 30.69% | 20.51% | 8.19% |
| Mar 31, 2018 | 26.47% | 11.94% | 32.21% | 22.20% | 7.71% |
| Mar 31, 2017 | 20.24% | 6.30% | 33.71% | 17.94% | 7.60% |
| Mar 31, 2016 | 19.76% | 15.27% | 34.95% | 18.35% | 7.03% |
| Mar 31, 2015 | 12.45% | 14.05% | 31.04% | 18.59% | 7.05% |
| Mar 31, 2014 | 4.55% | 12.84% | 25.56% | 22.42% | 7.92% |
| Mar 31, 2013 | 10.46% | 12.03% | 37.64% | 26.53% | 7.90% |
| Mar 31, 2012 | 1.20% | 20.28% | 40.30% | 0.00% | 8.42% |
| Mar 31, 2011 | -11.06% | 14.81% | 39.54% | 0.00% | 8.36% |
| Mar 31, 2010 | -29.26% | 17.31% | 39.29% | 0.00% | 8.41% |
| Mar 31, 2009 | -40.32% | 20.27% | 35.87% | 0.00% | 7.35% |
| Mar 31, 2008 | -61.90% | 19.28% | 35.53% | 0.00% | 6.54% |
| Mar 31, 2007 | -56.29% | 17.67% | 34.41% | 0.00% | 10.57% |
| Mar 31, 2006 | -69.36% | 9.09% | 28.81% | 0.00% | 9.88% |
| Mar 31, 2005 | -8.51% | 19.53% | 30.25% | 0.00% | 11.98% |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).